In stock · depth page
TB-500 / thymosin β4 fragment context (RUO)
Thymosin β4 literature identity · TB-500 catalog alias
BPC-157 10 mg + TB-500 10 mg blend · alias note
For laboratory research use only. Not for human or veterinary use, consumption, compounding into a medicine, or injection. Not authorized by Health Canada. Literature on this page is scientific context only. This page is not a licensed drug, a wellness protocol, or a dosing guide.
Peer-reviewed literature overwhelmingly uses thymosin β4, not the vendor alias TB-500. Confirm sequence and mass on the lot COA before the blend is released to the bench.
Naming map
Thymosin β4 / Tβ4 is the full-length endogenous peptide discussed in regenerative reviews. TB-500 is the research-catalog alias associated with thymosin β4 or related fragment language. The blend vial is BPC-157 plus that reference at 10 mg + 10 mg: one SKU line, dual identity on the certificate.
No primary analytical paper is listed that equates every commercial TB-500 lot to full-length thymosin β4. Match sequence and mass on the lot COA.
Write TB-500 / thymosin β4 per the lot COA on internal receiving notes. Request mass-spec identity and HPLC purity for the blend lot. Do not substitute a GH-axis secretagogue for a repair-class purchase order.
Identity
Form
Lyophilized blend, sealed vial
Strength
10 mg + 10 mg lyophilized blend
Purity
≥99% HPLC (see the lot COA)
CAS
- Thymosin β4 / TB-500: 77591-33-4
PubMed
Selected literature
- PMID 22074294 (2012) Goldstein & Kleinman, Expert Opinion on Biological Therapy — thymosin β4 multi-functional regenerative review
- PMID 25921810 (2017) Kim et al., Journal of Tissue Engineering and Regenerative Medicine — thymosin β4 in a dermal burn-wound model
Recent literature (2023–2026): No primary analytical paper is listed that equates every commercial TB-500 lot to full-length thymosin β4. Match sequence and mass on the lot COA.
Literature is scientific context only. A paper does not make a research vial into a licensed medicine.
Bench reconstitution
The catalog parent is one lyophilized cake: 10 mg BPC-157 and 10 mg TB-500. Dissolve the entire cake in one bacteriostatic-water volume to the combined mg/mL the protocol specifies. Swirl until no solids remain. Do not vortex. Record solvent lot and time. This is a reconstitution volume, not a clinical dose, and it is not a standalone BPC-157 or TB-500 vial.
Diluent page: bacteriostatic water.
Storage
Keep the lyophilized vial at 2–8 °C, protected from light and moisture, until the bench protocol calls for it. After reconstitution, hold at 2–8 °C; use within the sterility window your laboratory controls allow. Do not freeze–thaw repeatedly. Record open date and concentration in the notebook. Confirm the lot COA before you adopt a hold time.
Certificate of analysis
Every product has a View COA button. Where the lot certificate of analysis (identity and HPLC purity) is posted, it opens the certificate with a PDF download. Where it is not posted yet, the same button sends a request by email to request@pharmapeptidesrx.com, or you can write that address with the SKU. This page is not a COA.
Lab FAQ
Can the laboratory order TB-500 only from this parent?
No. The catalog parent is the blend. There is no standalone TB-500 SKU on this page. Write request@pharmapeptidesrx.com for lot documents. This page does not publish prices or banking details. Invoices go out from request@ only.
In this library
In stock · list price
Request from the catalog
Every vial on the catalog shows its CAD list price. Add it to your request and we email the invoice. Labs pay by Interac e-Transfer. No card checkout.